Related Experiment Video
Updated: Mar 22, 2026

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
Hypertensive crisis in children: an experience in a single tertiary care center in Korea
Geum Hwa Lee1, I Re Lee1, Se Jin Park2
1Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea.
Insights
Hypertensive crisis in children is often caused by kidney disease or cancer. Nicardipine and labetalol are effective intravenous drugs for managing this condition, showing similar blood pressure reduction and clinical outcomes.
Area of Science:
- Pediatric Nephrology
- Pediatric Cardiology
- Pediatric Oncology
Background:
- Hypertensive crisis is a critical medical condition with potential for severe end-organ damage.
- Etiology, treatment, and outcomes of hypertensive crisis in Korean children remain under-researched.
- This study investigates the causes and drug efficacy for hypertensive crisis in pediatric patients in Korea.
Purpose of the Study:
- To identify the primary etiologies of hypertensive crisis in Korean children.
- To evaluate the effectiveness of various intravenous antihypertensive drugs.
- To compare outcomes between hypertensive emergency and urgency in pediatric patients.
Main Methods:
- Retrospective analysis of 51 children diagnosed with hypertensive crisis (2010-2014).
- Patients categorized into hypertensive emergency (n=31) and hypertensive urgency (n=20) groups.
- Comparison of baseline etiologies, risk factors, and blood pressure response to intravenous antihypertensives.
Main Results:
- Kidney injury and cancer were identified as common underlying causes.
- Cardiovascular, central nervous system, and retinal complications were more prevalent in hypertensive emergency.
- Hydralazine was initially used but often ineffective; nicardipine, labetalol, or nitroprusside were subsequently administered in 45.1% of cases.
- Nicardipine and labetalol demonstrated comparable efficacy in reducing blood pressure and improving clinical outcomes.
Conclusions:
- Children with underlying renal diseases and cancer require vigilant blood pressure monitoring and examination.
- Nicardipine and labetalol are effective options for intravenous management of hypertensive crisis in pediatric populations.
- Further research into pediatric hypertensive crisis management is warranted.
Background:
Hypertensive crisis is a medical emergency that can cause acute damage to multiple end-organs. However, relatively little is known on the etiology, treatment, and outcomes of hypertensive crisis in Korean children. The aim of this study was to determine the etiologies and efficacy of drugs for hypertensive crisis in children during the past 5 years at a single center in Korea.
Methods:
We analyzed data from 51 children with hypertensive crisis during the period between January 1, 2010 and April 1, 2014. The patients were divided into two groups: those diagnosed with a hypertensive emergency (hypertension with organ injury, n = 31) and those diagnosed with a hypertensive urgency (hypertension without organ injury, n = 20). Baseline etiologies and risk factors were compared between the two groups. In addition, systolic and diastolic blood pressures were evaluated at 1, 2, 4, and 5 hours after the administration of intravenous antihypertensive drugs.
Results:
Kidney injury and cancer were the common causes in patients with hypertensive crisis. Cardiovascular complications (cardiac hypertrophy) (p = 0.002), central nervous system complications (p = 0.004), and retinopathy (p = 0.034) were more frequently observed in children with hypertensive emergency than those with hypertensive urgency. However, the proportion of renal complications was similar in both groups. Hydralazine was most commonly used in both groups to control acute increasing blood pressure at first. However, it was often ineffective for controlling abrupt elevated blood pressure. Therefore, intravenous antihypertensive drugs were changed from hydralazine to nicardipine, labetalol, or nitroprusside to control the high blood pressure in 45.1 % of the patients. Particularly, in patients with hypertensive crisis, there was no significant difference in reduction of systolic and diastolic blood pressure and in improvement of clinical outcomes between nicardipine and labetalol administration.
Conclusion:
Close blood pressure monitoring and careful examinations should be mandatory in children with underlying disease, especially renal diseases and cancer. Furthermore, both nicardipine and labetalol may be effective antihypertensive drug in lowering high blood pressure in children with hypertensive crisis.
Related Concept Videos
Hypertension I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Hypertension II: Pathophysiology
Hypertension V: Nursing Management

